Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis

BACKGROUND: The combination of tyrosine kinase inhibitors (TKIs) and transarterial chemoembolization (TACE) fulfills an important role in the treatment of unresectable hepatocellular carcinoma (uHCC). Among the combination therapies, both lenvatinib and sorafenib combined with TACE are recommended a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun-Ning, Li, Ji-Jiang, Yan, Shu, Zhang, Guang-Nian, Yi, Peng-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995877/
https://www.ncbi.nlm.nih.gov/pubmed/36910612
http://dx.doi.org/10.3389/fonc.2023.1074793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995877/
https://www.ncbi.nlm.nih.gov/pubmed/36910612
http://dx.doi.org/10.3389/fonc.2023.1074793

Ejemplares similares